Cargando…

Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial

BACKGROUND: Urinary tract infections (UTIs) are common and result in an enormous economic burden. The increasing prevalence of antibiotic-resistant microorganisms has stimulated interest in non-antibiotic agents to prevent UTIs. OBJECTIVE: To evaluate the cost-effectiveness of cranberry prophylaxis...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosmans, Judith E., Beerepoot, Mariëlle A. J., Prins, Jan M., ter Riet, Gerben, Geerlings, Suzanne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976255/
https://www.ncbi.nlm.nih.gov/pubmed/24705418
http://dx.doi.org/10.1371/journal.pone.0091939
_version_ 1782310260678066176
author Bosmans, Judith E.
Beerepoot, Mariëlle A. J.
Prins, Jan M.
ter Riet, Gerben
Geerlings, Suzanne E.
author_facet Bosmans, Judith E.
Beerepoot, Mariëlle A. J.
Prins, Jan M.
ter Riet, Gerben
Geerlings, Suzanne E.
author_sort Bosmans, Judith E.
collection PubMed
description BACKGROUND: Urinary tract infections (UTIs) are common and result in an enormous economic burden. The increasing prevalence of antibiotic-resistant microorganisms has stimulated interest in non-antibiotic agents to prevent UTIs. OBJECTIVE: To evaluate the cost-effectiveness of cranberry prophylaxis compared to antibiotic prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) over a 12 month period in premenopausal women with recurrent UTIs. MATERIALS AND METHODS: An economic evaluation was performed alongside a randomized trial. Primary outcome was the number of UTIs during 12 months. Secondary outcomes included satisfaction and quality of life. Healthcare utilization was measured using questionnaires. Missing data were imputed using multiple imputation. Bootstrapping was used to evaluate the cost-effectiveness of the treatments. RESULTS: Cranberry prophylaxis was less effective than TMP-SMX prophylaxis, but the differences in clinical outcomes were not statistically significant. Costs after 12 months in the cranberry group were statistically significantly higher than in the TMP-SMX group (mean difference €249, 95% confidence interval 70 to 516). Cost-effectiveness planes and cost-effectiveness acceptability curves showed that cranberry prophylaxis to prevent UTIs is less effective and more expensive than (dominated by) TMP-SMX prophylaxis. CONCLUSION: In premenopausal women with recurrent UTIs, cranberry prophylaxis is not cost-effective compared to TMP-SMX prophylaxis. However, it was not possible to take into account costs attributed to increased antibiotic resistance within the framework of this randomized trial; modeling studies are recommended to investigate these costs. Moreover, although we based the dosage of cranberry extract on available evidence, this may not be the optimal dosage. Results may change when this optimal dosage is identified. TRIAL REGISTRATION: ISRCTN.org ISRCTN50717094
format Online
Article
Text
id pubmed-3976255
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39762552014-04-08 Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial Bosmans, Judith E. Beerepoot, Mariëlle A. J. Prins, Jan M. ter Riet, Gerben Geerlings, Suzanne E. PLoS One Research Article BACKGROUND: Urinary tract infections (UTIs) are common and result in an enormous economic burden. The increasing prevalence of antibiotic-resistant microorganisms has stimulated interest in non-antibiotic agents to prevent UTIs. OBJECTIVE: To evaluate the cost-effectiveness of cranberry prophylaxis compared to antibiotic prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) over a 12 month period in premenopausal women with recurrent UTIs. MATERIALS AND METHODS: An economic evaluation was performed alongside a randomized trial. Primary outcome was the number of UTIs during 12 months. Secondary outcomes included satisfaction and quality of life. Healthcare utilization was measured using questionnaires. Missing data were imputed using multiple imputation. Bootstrapping was used to evaluate the cost-effectiveness of the treatments. RESULTS: Cranberry prophylaxis was less effective than TMP-SMX prophylaxis, but the differences in clinical outcomes were not statistically significant. Costs after 12 months in the cranberry group were statistically significantly higher than in the TMP-SMX group (mean difference €249, 95% confidence interval 70 to 516). Cost-effectiveness planes and cost-effectiveness acceptability curves showed that cranberry prophylaxis to prevent UTIs is less effective and more expensive than (dominated by) TMP-SMX prophylaxis. CONCLUSION: In premenopausal women with recurrent UTIs, cranberry prophylaxis is not cost-effective compared to TMP-SMX prophylaxis. However, it was not possible to take into account costs attributed to increased antibiotic resistance within the framework of this randomized trial; modeling studies are recommended to investigate these costs. Moreover, although we based the dosage of cranberry extract on available evidence, this may not be the optimal dosage. Results may change when this optimal dosage is identified. TRIAL REGISTRATION: ISRCTN.org ISRCTN50717094 Public Library of Science 2014-04-04 /pmc/articles/PMC3976255/ /pubmed/24705418 http://dx.doi.org/10.1371/journal.pone.0091939 Text en © 2014 Bosmans et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Bosmans, Judith E.
Beerepoot, Mariëlle A. J.
Prins, Jan M.
ter Riet, Gerben
Geerlings, Suzanne E.
Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial
title Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial
title_full Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial
title_fullStr Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial
title_full_unstemmed Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial
title_short Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial
title_sort cost-effectiveness of cranberries vs antibiotics to prevent urinary tract infections in premenopausal women: a randomized clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976255/
https://www.ncbi.nlm.nih.gov/pubmed/24705418
http://dx.doi.org/10.1371/journal.pone.0091939
work_keys_str_mv AT bosmansjudithe costeffectivenessofcranberriesvsantibioticstopreventurinarytractinfectionsinpremenopausalwomenarandomizedclinicaltrial
AT beerepootmarielleaj costeffectivenessofcranberriesvsantibioticstopreventurinarytractinfectionsinpremenopausalwomenarandomizedclinicaltrial
AT prinsjanm costeffectivenessofcranberriesvsantibioticstopreventurinarytractinfectionsinpremenopausalwomenarandomizedclinicaltrial
AT terrietgerben costeffectivenessofcranberriesvsantibioticstopreventurinarytractinfectionsinpremenopausalwomenarandomizedclinicaltrial
AT geerlingssuzannee costeffectivenessofcranberriesvsantibioticstopreventurinarytractinfectionsinpremenopausalwomenarandomizedclinicaltrial